Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Lessons Learned From a Randomized Controlled Trial of a Family-Based Intervention to Promote School Functioning for School-Age Children With Sickle Cell Disease
source: Journal of Pediatric Psychology
authors: Daniel LC, Li Y, Smith K, Tarazi R, Robinson MR, Patterson CA, Smith-Whitley K, Stuart M, Barakat LPsummary/abstract:
Tested a family-based group problem-solving intervention, “Families Taking Control,” (FTC) to improve school functioning and health-related quality of life (HRQL) for children with sickle cell disease.
Children and caregivers completed questionnaires assessing HRQL and school functioning and children completed performance-based measures of IQ and achievement at baseline and 6 months later. Families were randomized to the intervention (FTC, n = 42) or delayed intervention control (DIC, n = 41) group. FTC involved a full-day workshop followed by 3 booster calls.
There were no differences between FTC completers (n = 24) and noncompleters (n = 18). FTC group (n = 24) and DIC group (n = 38) did not differ significantly on primary outcomes at follow-up: number of formal academic and disease-related accommodations, individualized education plan/504 service plan, school absences, school HRQL, or academic skills.
Although families found FTC to be acceptable, there were no intervention effects. Challenges of the trial and implications for future research are discussed.
read more full text
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
Jeffrey Andolina, MD, MSDr. Andolina is the director of pediatri...
Methodist Comprehensive Sickle Cell CenterMethodist Comprehensive Sickle Cell Cent...
Sickle Cell Pulmonary Clinic, Connecticut Children’s Medical CenterConnecticut Children’s is one of the f...
Rita Paschal, MDDr. Paschal is Associate Professor of me...
Sickle Cell in Focus Conference 2018After an exciting event in Kingston, Jam...
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.